NCT04540107 - Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Recurrent World Health Organization (WHO) Grade II GliomaRecurrent WHO Grade III GliomaWHO Grade II GliomaWHO Grade III Glioma

Interventions

DRUG

Hyperpolarized Carbon C 13 Pyruvate

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MRSI

Trial Locations (1)

RECRUITING

University of California, San Francisco, San Francisco